Countdown to 2015 for Maternal, Newborn and Child Survival

Tracking The Issue FAQs Francais
Home > Programme > Plenary 2
Plenary session 2 - Policies and health systems that work for the health-related MDGs PDF Print E-mail
Co-chairs: 
H.E. Kumbo Kachali, Minister of Health, Malawi and
Ms Purnima Mane, Deputy Executive Director, UNFPA
 
Health systems, policies, and the Countdown:  Dr Bernadette Daelmans, WHO
Dr Bernadette Daelmans presented an overview of the findings related to the health systems and policies indicators tracked in the 2008 Countdown report.  In her presentation, she described the rationale for assessing the policy environment, and health systems factors (e.g. human resources and health financing) for MNCH and reviewed the conceptual and methodological framework used to collect and analyze the relevant data, and summarized the main findings
Dr Bernadette Daelmans

Tracking External Resources for MNCH: Dr Jo Borghi, Ms Giulia Greco

Dr Jo Borghi and Ms Giulia Greco, London School of Hygiene and Tropical Medicine, co-presented

The study on financial flows for the Countdown 2008 report looks specifically at donor flows in 2005 and 2006, and trends between 2003-2006 and explores the determinants of aid flows including where and how much donors choose to invest.  Dr Borghi noted the large funding gap for maternal, newborn and child health (MNCH) to meet MDGs 4 and 5.

Ms Greco noted that total aid to MNCH increased from 2 billion in 2003 to 3.5 billion in 2006, with development assistance( ODA) to child health increasing by 63%, and ODA to maternal and newborn health increasing by 66% in the same time. She also noted that per capita aid to the 68 countries nearly doubled, but that the increases in aid were uneven across the countries, with some experiencing reductions.  Ms Greco concluded that  there have been general increases in funding to MNCH , but that more resources are needed to achieve MDGs 4 and 5, and predictability is key.

Tackling the Human Resources Crisis: Dr Francis Omaswa Executive Director, The Global Health Workforce Alliance

In terms of the Countdown priority countries, Dr Francis Omaswa noted that the 57 countries with a critical health worker shortage overlaps with the 68 priority countries and is a clear indication of the direct connection between high MNC mortality and health work force density.           

Dr Omaswa concluded his presentation by listing solutions to the health workforce crisis that were identified in the Kampala Declaration and Agenda for Global Action, March 2008:  leadership, capacity building, training for health workers,  use of community and mid-level workers, the establishment of partnerships, strengthening of health care societies. 
 
Discussion and Conclusion
 
Co-Chairs
Monir Islam and H.E. Dr Malick Nije
 
Each of the five break-out groups reported the main outcomes from their respective sessions. Following their summary presentations, Dr Monir Islam and H.E. Dr Malick Nije facilitated discussion on the presentations and how the findings of the break-out sessions can be transformed into concrete actions for improving MNCH 
Dr Monir Islam
 
Break-out Session Summaries
 
Group 1:   High impact MNCH policy: evidence and experience on the political processes and policy decisions that make a difference.

Dr Jeffrey Mecaskey, Save the Children US, provided an overview of the experiences of Tanzania and Nepal and the perspective of the World Bank on the role of policy in influencing MNCH. 

Group 2:  Show me the money!  The financing cycle of maternal, newborn, and child health

Dr Tessa Tantores, WHO explained that the focus of the break-out session was on learning from country-based experiences concrete strategies that civil society and other partners can adopt to increase money allocated to MNCH.

Group 3:  Results-based financing: evidence and experience on how changing incentives can affect MNCH service uptake and delivery

Dr Giorgio Cometto, Save the Children UK discussed results-based financing schemes in Rwanda, Afghanistan, and China to increase service delivery for MNCH showed that the success of these schemes hinges upon clear delineation of their costing and resource implications, and the capacity for good monitoring and evaluation. 

Group 4:  Human resources for MNCH
Dr David Sanders, University of Cape Town, reviewed the outcomes of group 4 and the presentations given about the experiences of Brazil, India, and Ghana.

Group 5: Quality of health services:  making the difference

The group noted that in order to assess the quality of health services, better indicators of the quality of care need to be developed and used.  It was recommended that these indicators be developed with specificity to specific areas or issues (e.g., malaria, HIV, etc.) and that the Countdown put more emphasis on this area in 

Dr Monir Islam called upon audience participants to provide specific ways for improving the flow of resources for MNCH. 

    • The Minister of Health from Mozambique, Dr Paul Ivo Garrido, suggested that better communication between the ministers of finance and health is essential.  They promised to return home to underline the importance of maternal, newborn and child health and develop and strengthen a more decentralized health system and focus on the  training of health workers.
    • Dr Richard Horton, The Lancet,  implored those in attendance to do more to attract the participation of the media so that MNCH is better spotlighted and becomes an issue that can no longer be ignored.
    • Mrs Ann Tinker, Save the Children,  underlined that the role of NGOs and civil society in delivering services and in advocating for women and children must be recognized. She also argued that there is currently too much competition for resources and stressed better cooperation and integration  with communities.

From the floor

    • A parliamentarian from the audience commented that parliamentarians need correct statistics and other relevant information in order to present a convincing case to their governments about why investments in MNCH should be increased (e.g, that the status of MNCH is a problem, and economic returns on investments in MNCH).
    • Ms Kate Taylor, Glaxo-Smith Pharmaceuticals, suggested building stronger ties between the private and public sector, and noted that the private sector should be viewed as an important ally in advocacy.

    All images © WHO/Giacomo Pirozzi